|
88
|
287
|
3k5vA |
Structure of abl kinase in complex with imatinib and gnf-2 |
|
118
|
410
|
3k2lA |
Crystal structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (dyrk2) |
|
78
|
271
|
3jvsA |
Characterization of the chk1 allosteric inhibitor binding site |
|
107
|
348
|
3k3jA |
P38alpha bound to novel dfg-out compound pf-00416121 |
|
80
|
274
|
3jxwA |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
83
|
269
|
3k5uA |
Identification, sar studies and x-ray cocrystal analysis of a novel furano-pyrimidine aurora kinase a inhibitor |
|
81
|
274
|
3jyaA |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
113
|
348
|
3k3iA |
P38alpha bound to novel dgf-out compound pf-00215955 |
|
114
|
334
|
3juhA |
Crystal structure of a mutant of human protein kinase ck2alpha with altered cosubstrate specificity |
|
88
|
302
|
3js2A |
Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid |
|
81
|
271
|
3jvrA |
Characterization of the chk1 allosteric inhibitor binding site |
|
82
|
273
|
3jpvA |
Crystal structure of human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and a pyrrolo[2,3-a]carbazole ligand |
|
97
|
289
|
3iokA |
2-aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of jak2 |
|
76
|
272
|
3is5A |
Crystal structure of cdpk kinase domain from toxoplasma gondii, tgme49_018720 |
|
112
|
349
|
3iphA |
Crystal structure of p38 in complex with a biphenylamide inhibitor |
|
109
|
350
|
3iw6A |
Human p38 map kinase in complex with a benzylpiperazin-pyrrol |
|
96
|
289
|
3io7A |
2-aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of jak2 |
|
110
|
357
|
3itzA |
Crystal structure of p38a mitogen-activated protein kinase in complex with a pyrazolopyridazine inhibitor |
|
80
|
285
|
3iopA |
Pdk-1 in complex with the inhibitor compound-8i |
|
105
|
350
|
3iw5A |
Human p38 map kinase in complex with an indole derivative |
|
107
|
349
|
3iw8A |
Structure of inactive human p38 map kinase in complex with a thiazole-urea |
|
81
|
285
|
3ionA |
Pdk1 in complex with compound 8h |
|
86
|
339
|
3iw4A |
Crystal structure of pkc alpha in complex with nvp-aeb071 |
|
113
|
328
|
3iq7A |
Crystal structure of human haspin in complex with 5-iodotubercidin |
|
103
|
349
|
3iw7A |
Human p38 map kinase in complex with an imidazo-pyridine |
|
80
|
325
|
3ikaA |
Crystal structure of egfr 696-1022 t790m mutant covalently binding to wz4002 |
|
82
|
298
|
3iggA |
Novel cdk-5 inhibitors - crystal structure of inhibitor efq with cdk-2 |
|
150
|
465
|
3i7cA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with bumped kinase inhibitor na-pp2 |
|
82
|
298
|
3ig7A |
Novel cdk-5 inhibitors - crystal structure of inhibitor efp with cdk-2 |
|
152
|
469
|
3igoA |
Crystal structure of cryptosporidium parvum cdpk1, cgd3_920 |
|
93
|
302
|
3i81A |
Crystal structure of insulin-like growth factor 1 receptor (igf-1r-wt) complex with bms-754807 [1-(4-((5-cyclopropyl-1h-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-n-(6-fluoro-3-pyridinyl)-2-methyl-l-prolinamide] |
|
75
|
273
|
3ii5A |
The complex of wild-type b-raf with pyrazolo pyrimidine inhibitor |
|
101
|
315
|
3iecA |
Helicobacter pylori caga inhibits par1/mark family kinases by mimicking host substrates |
|
88
|
286
|
3ik3A |
Ap24534, a pan-bcr-abl inhibitor for chronic myeloid leukemia, potently inhibits the t315i mutant and overcomes mutation-based resistance |
|
154
|
463
|
3i79A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) |
|
72
|
272
|
3idpA |
B-raf v600e kinase domain in complex with an aminoisoquinoline inhibitor |
|
108
|
343
|
3idbA |
Crystal structure of (108-268)riib:c holoenzyme of camp-dependent protein kinase |
|
94
|
343
|
3idcA |
Crystal structure of (102-265)riib:c holoenzyme of camp-dependent protein kinase |
|
159
|
462
|
3i7bA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with bumped kinase inhibitor nm-pp1 |
|
106
|
351
|
3i60A |
Crystal structure of erk2 bound to (s)-4-(2-(2-chlorophenylamino)-5-methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-pyrrole-2-carboxamide |
|
116
|
328
|
3i1aA |
Crystal structure of apo spectinomycin phosphotransferase, aph(9)-ia |
|
71
|
262
|
3hyhA |
Crystal structure of the protein kinase domain of yeast amp-activated protein kinase snf1 |
|
101
|
348
|
3hv7A |
Human p38 map kinase in complex with rl38 |
|
87
|
295
|
3i5nA |
Crystal structure of c-met with triazolopyridazine inhibitor 13 |
|
102
|
348
|
3hvcA |
Crystal structure of human p38alpha map kinase |
|
84
|
284
|
3hrcA |
Crystal structure of a mutant of human pdk1 kinase domain in complex with atp |
|
86
|
327
|
3i0qA |
Crystal structure of the amp-bound complex of spectinomycin phosphotransferase, aph(9)-ia |
|
107
|
350
|
3hv3A |
Human p38 map kinase in complex with rl49 |
|
165
|
474
|
3hx4A |
Crystal structure of cdpk1 of toxoplasma gondii, tgme49_101440, in presence of calcium |
|
106
|
347
|
3hp5A |
Crystal structure of human p38alpha complexed with a pyrimidopyridazinone compound |
